H-1B sponsorNYUpdated Jun 2026
DROGA5, LLC
US H-1B Labor Condition Application activity for DROGA5, LLC. Filed 209 disclosures between FY2010 and FY2022 from worksites with a NY headquarters indicator.
Total filings
3
Outside top-N · FY2022
Certified
100.0%
unconditional · FY2022
Withdrawn
0.0%
withdrawn rate · FY2022
Denied
0.0%
rejection rate · FY2022
Outcome breakdown
Share of DROGA5, LLC’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
Certified100.0%
Top occupations sponsored
SOC codes filed most by DROGA5, LLC across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 27-1011 | Art Directors | 55 |
| 2 | 27-3043 | Writers and Authors | 25 |
| 3 | 41-9031 | Sales Engineers | 19 |
| 4 | 13-2011 | Accountants and Auditors | 17 |
| 5 | 27-1024 | Graphic Designers | 11 |
| 6 | 27-3099 | Media and Communication Workers, All Other | 8 |
| 7 | 13-1161 | Market Research Analysts and Marketing Specialists | 7 |
| 8 | 43-1011 | First-Line Supervisors of Office and Administrative Support Workers | 7 |
| 9 | 27-2012 | Producers and Directors | 7 |
| 10 | 15-2031 | Operations Research Analysts | 6 |
Art Directors
55
Writers and Authors
25
Sales Engineers
19
Accountants and Auditors
17
Graphic Designers
11
Media and Communication Workers, All Other
8
Market Research Analysts and Marketing Specialists
7
First-Line Supervisors of Office and Administrative Support Workers
7
Producers and Directors
7
Operations Research Analysts
6
Filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 2 |
| FY2011 | 15 |
| FY2012 | 9 |
| FY2013 | 20 |
| FY2014 | 12 |
| FY2015 | 32 |
| FY2016 | 30 |
| FY2017 | 39 |
| FY2018 | 22 |
| FY2019 | 22 |
| FY2020 | 2 |
| FY2021 | 1 |
| FY2022 | 3 |
Compare DROGA5, LLC with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Explore by rank
Pre-built leaderboards for the most-asked questions.